Litcius/Paper detail

Phase 1 study of the safety, pharmacokinetics, and preliminary efficacy of CA102N as monotherapy and in combination with trifluridine-tipiracil in patients with locally advanced or metastatic solid tumors

Shubham Pant, Tomislav Dragovich, Christopher H. Lieu, Antonio Jimeno, Madappa N. Kundranda, David G. Menter, Eskouhie Tchaparian, Yuchih C. Chen, Scott Kopetz

2022Investigational New Drugs10 citationsDOI

Topics & Concepts

MedicineAdverse effectPharmacokineticsPharmacodynamicsInternal medicinePharmacologyPhases of clinical researchTolerabilityGastroenterologyOncologyChemotherapyColorectal Cancer Treatments and StudiesCancer Treatment and PharmacologyLung Cancer Treatments and Mutations
Phase 1 study of the safety, pharmacokinetics, and preliminary efficacy of CA102N as monotherapy and in combination with trifluridine-tipiracil in patients with locally advanced or metastatic solid tumors | Litcius